Nanomedicine: a technology for tomorrow
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: SHAMIM, Sumbul (Dow University of Health Sciences, Pharmaceutical Sciences (Pharmacology), Karachi, Pakistan)
Background: A number of new molecular entities (NMEs) selected for full-scale development based on their safety and pharmacological data suffer from undesirable physicochemical and biopharmaceutical properties, which lead to poor pharmacokinetics and distribution after in vivo administration. An optimization of the preformulation studies to.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.